Health Care & Life Sciences » Pharmaceuticals | AcelRx Pharmaceuticals Inc.

AcelRx Pharmaceuticals Inc.

AcelRx Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
60.6 M
Public Float
40.79 M
AcelRx Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.76
Market Cap
$193.34 M
Shares Outstanding
78.91 M
Public Float
67.11 M

Profile

Address
351 Galveston Drive
Redwood City California 94063
United States
Employees -
Website http://www.acelrx.com
Updated 07/08/2019
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of acute pain. Its products include DSUVIA and ZALVISO. The company was founded by Thomas A.

Financials

View All

Vincent J. Angotti
Chief Executive Officer & Director
Pamela Pierce Palmer
Director & Chief Medical Officer